Lavie Bio's Activity was Sold to ICL

We’re pleased to share that Lavie Bio's (Evogene’s subsidiary) activity has been acquired by ICL, marking an exciting new chapter for its technology and innovation. Read more

As part of this transition, the Lavie Bio website is no longer active.
For more information, please visit www.evogene.com or contact us at info@evogene.com